![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Fresenius Kabi Austria Gmbh Linz At, based in Austria, is a pharmaceutical company.
One of their significant offerings is Lactulose, liquid, with sodium benzoate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2015-187 - Rev 00
This Chemical Type CEP, issued on October 30, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 924 associated with this CEP further emphasizes